XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.2
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2019
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatement of Previously Issued Financial Statements

The effect of the restatements on the unaudited financial statements for March 31, 2019 and 2018 are as follows:

 

   For the Quarter Ended March 31, 2019 
   As Reported   Restatement Adjustment   As Restated 
Statement of Operations:               
Revenue  $5,036,346   $-   $5,036,346 
Cost of revenue   2,043,028    -    2,043,028 
Selling, general and administrative expenses   2,069,040    -    2,069,040 
Depreciation and amortization expense   1,011,105    -    1,011,105 
Total operating costs and expenses   5,123,173    -    5,123,173 
Operating income (loss)   (86,827)   -    (86,827)
Other income (expense)               
Interest income   123,386    (104,453)   18,933 
Interest expense   (177,982)   -    (177,982)
Total other expense   (54,596)   (104,453)   (159,049)
Net income (loss)   (141,423)   (104,453)   (245,876)
Income tax expense   -    -    - 
Net income (loss)   (141,423)   (104,453)   (245,876)
Earnings (loss) per common share - basic  $(0.01)  $-   $(0.01)
Earnings (loss) per common share - diluted  $(0.01)  $-   $(0.01)
Weighted average common shares outstanding - basic   25,018,098    -    25,018,098 
Weighted average common shares outstanding - diluted   25,018,098    -    25,018,098 
Balance Sheet:               
Current assets  $8,730,573   $(104,453)  $8,626,120 
Total assets   27,389,452    (7,471,665)   19,917,787 
Current liabilities   6,608,084    -    6,608,084 
Total liabilities   12,571,592    -    12,571,592 
Total shareholders’ equity   14,817,860    (7,471,665)   7,346,195 
Total liabilities and shareholders’ equity   27,389,452    (7,471,665)   19,917,787 

 

   For the Quarter Ended March 31, 2018 
   As Reported   Restatement Adjustment   As Restated 
Statement of Operations:               
Revenue  $4,600,293   $-   $4,600,293 
Cost of revenue   1,798,944    -    1,798,944 
Selling, general and administrative expenses   1,697,663    -    1,697,663 
Depreciation and amortization expense   936,027    -    936,027 
Total operating costs and expenses   4,432,634    -    4,432,634 
Operating income (loss)   167,659    -    167,659 
Other income (expense)               
Interest income   92,428    (86,287)   6,141 
Interest expense   (191,553)   -    (191,553)
Total other expense   (99,125)   (86,287)   (185,412)
Net income (loss)   68,534    (86,287)   (17,753)
Income tax expense   -    -    - 
Net income (loss)   68,534    (86,287)   (17,753)
Earnings (loss) per common share - basic  $0.00   $-   $(0.00)
Earnings (loss) per common share - diluted  $0.00   $-   $(0.00)
Weighted average common shares outstanding - basic   24,535,155    -    24,535,155 
Weighted average common shares outstanding - diluted   25,140,646    -    24,535,155 
Balance Sheet:               
Current assets  $6,728,071   $(86,287)  $6,641,784 
Total assets   28,210,450    (7,453,499)   20,756,951 
Current liabilities   9,055,574    -    9,055,574 
Total liabilities   13,702,323    -    13,702,323 
Total shareholders' equity   14,508,127    (7,453,499)   7,054,628 
Total liabilities and shareholders' equity   28,210,450    (7,453,499)   20,756,951